Skip to content
Citation only via Europe PMC

Predictors of loss to follow-up in neovascular age-related macular degeneration.

Huang RS, Naidu SC, Mihalache A, Xie JS, Popovic MM, Kertes PJ, Sarraf D, Sadda SR, Muni RH, Kohly RP.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026

Abstract

<h4>Objective</h4>To investigate the demographic, clinical, and treatment-related risk factors associated with being lost to follow-up (LTFU) among patients with neovascular age-related macular degeneration (nAMD) receiving antivascular endothelial growth factor (anti-VEGF) intravitreal injections (IVIs).<h4>Methods</h4>We conducted a multicentre retrospective cohort study of patients with nAMD treated with anti-VEGF IVIs in Toronto, Ontario, from January 2012 to December 2021. LTFU was defined as the absence of an ophthalmic visit within 1 year of the last retinal specialist appointment. Univariable and multivariable logistic regression analyses were conducted to examine associations between demographic, clinical, and treatment-related factors and becoming LTFU.<h4>Results</h4>Among 2556 patients with nAMD, 527 (21%) were LTFU over a mean follow-up of 65.5 ± 15.2 months. In multivariable analysis, male sex (OR = 1.40; p < .001), greater travel distance (>200 km; OR = 2.51; p < .001), and multiple systemic comorbidities (≥3; OR = 1.39; p = .01) were associated with higher odds of LTFU. Compared with White patients, Black (OR = 2.07; p < .001) and Hispanic patients (OR = 1.70; p < .001) had increased odds of LTFU. In contrast, age ≥90 years (OR = 0.53; p < .001), worse baseline visual acuity (>20/200; OR = 0.72; p = .03), pseudophakia (OR = 0.80; p = .04), bilateral disease (OR = 0.72; p = .01), and higher first-year anti-VEGF injection burden (OR = 0.55; p < .001) were associated with lower odds of LTFU.<h4>Conclusions</h4>Male sex, Black or Hispanic race/ethnicity, multiple systemic comorbidities, and greater travel distance were associated with increased odds of becoming LTFU, while older age, worse baseline visual acuity, pseudophakia, bilateral disease, and higher IVI burden were protective factors. These findings can inform the development of targeted retention strategies for high-risk patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.jcjo.2026.08.006
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
RS, H., SC, N., A, M., JS, X., MM, P., PJ, K., D, S., SR, S., RH, M., &amp; RP., K. (2026). Predictors of loss to follow-up in neovascular age-related macular degeneration. <em>Canadian journal of ophthalmology. Journal canadien d'ophtalmologie</em>. https://doi.org/10.1016/j.jcjo.2026.08.006
Vancouver
RS H, SC N, A M, JS X, MM P, PJ K, et al. Predictors of loss to follow-up in neovascular age-related macular degeneration. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2026. doi:10.1016/j.jcjo.2026.08.006.
BibTeX
@article{huang2026Predic, title = {Predictors of loss to follow-up in neovascular age-related macular degeneration.}, author = {Huang RS and Naidu SC and Mihalache A and Xie JS and Popovic MM and Kertes PJ and Sarraf D and Sadda SR and Muni RH and Kohly RP.}, journal = {Canadian journal of ophthalmology. Journal canadien d'ophtalmologie}, year = {2026}, doi = {10.1016/j.jcjo.2026.08.006}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings